线NLRP3:

Alireza Shadab1, Mohammad Abbasi-Kolli2, Mansoore Saharkhiz3

  • 1Deputy of Health, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.

概括

准线粒体功能障碍和NLRP3炎症酶可能为多发性硬化症 (MS) 提供新的治疗策略. 本综述探讨了改善线粒体功能的化合物,并抑制NLRP3炎症酶对MS的神经保护.